Loading…

Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study

In the era of personalized medical practice, understanding the genetic basis of patient-specific adverse drug reaction (ADR) is a major challenge. Clozapine provides effective treatments for schizophrenia but its usage is limited because of life-threatening agranulocytosis. A recent high impact stud...

Full description

Saved in:
Bibliographic Details
Published in:PLoS computational biology 2011-03, Vol.7 (3), p.e1002016
Main Authors: Yang, Lun, Wang, Kejian, Chen, Jian, Jegga, Anil G, Luo, Heng, Shi, Leming, Wan, Chunling, Guo, Xizhi, Qin, Shengying, He, Guang, Feng, Guoyin, He, Lin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c632t-d743999f8614c1b08024b88ed6d56abe09ed9aae1993958ba65749a958a66a1b3
cites cdi_FETCH-LOGICAL-c632t-d743999f8614c1b08024b88ed6d56abe09ed9aae1993958ba65749a958a66a1b3
container_end_page
container_issue 3
container_start_page e1002016
container_title PLoS computational biology
container_volume 7
creator Yang, Lun
Wang, Kejian
Chen, Jian
Jegga, Anil G
Luo, Heng
Shi, Leming
Wan, Chunling
Guo, Xizhi
Qin, Shengying
He, Guang
Feng, Guoyin
He, Lin
description In the era of personalized medical practice, understanding the genetic basis of patient-specific adverse drug reaction (ADR) is a major challenge. Clozapine provides effective treatments for schizophrenia but its usage is limited because of life-threatening agranulocytosis. A recent high impact study showed the necessity of moving clozapine to a first line drug, thus identifying the biomarkers for drug-induced agranulocytosis has become important. Here we report a methodology termed as antithesis chemical-protein interactome (CPI), which utilizes the docking method to mimic the differences in the drug-protein interactions across a panel of human proteins. Using this method, we identified HSPA1A, a known susceptibility gene for CIA, to be the off-target of clozapine. Furthermore, the mRNA expression of HSPA1A-related genes (off-target associated systems) was also found to be differentially expressed in clozapine treated leukemia cell line. Apart from identifying the CIA causal genes we identified several novel candidate genes which could be responsible for agranulocytosis. Proteins related to reactive oxygen clearance system, such as oxidoreductases and glutathione metabolite enzymes, were significantly enriched in the antithesis CPI. This methodology conducted a multi-dimensional analysis of drugs' perturbation to the biological system, investigating both the off-targets and the associated off-systems to explore the molecular basis of an adverse event or the new uses for old drugs.
doi_str_mv 10.1371/journal.pcbi.1002016
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1313184920</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A253627952</galeid><doaj_id>oai_doaj_org_article_3272010b712f4b77a742357fa97500fc</doaj_id><sourcerecordid>A253627952</sourcerecordid><originalsourceid>FETCH-LOGICAL-c632t-d743999f8614c1b08024b88ed6d56abe09ed9aae1993958ba65749a958a66a1b3</originalsourceid><addsrcrecordid>eNqVkttq3DAQhk1paQ7tG5TW0KteeKuDLVk3hRDSdCG00MO1GEuyo8WWFklesn2OPnC12U3IQm-KBBqNvvkHzUxRvMFogSnHH1d-Dg7GxVp1doERIgizZ8Upbhpacdq0z5_YJ8VZjCuEsinYy-KE4LqldYtPiz9Xd-vRB-uG0vd9lSAMJsUSnL6_x21MZopl70MJemNCNKUO81AGAypZ72K5sVCqWzNZBWO1Dj4Z60rrkgmZ8JOpKjX637C2zlTW6VkZXcIQwM2jV9vko83p8i4VZPGYZr19VbzoYYzm9eE8L359vvp5-aW6-Xa9vLy4qRSjJFWa11QI0bcM1wp3qEWk7trWaKYbBp1BwmgBYLAQVDRtB6zhtYBsAmOAO3pevNvr5hJEeSholJjm1daCoEws94T2sJLrYCcIW-nBynuHD4OEkKwajaSE5xagjmPS1x3nwGtCG96D4A1Cvcpanw7Z5m4yWhmXAoxHoscvzt7KwW8kRawVhGeB93uBAXI-63qfMTXZqOQFaSgjXDQkU4t_UHnpXY-8M73N_qOAD0cBmUnmLg0wxyiXP77_B_v1mK33rAo-xmD6x69iJHcj_FBxuRtheRjhHPb2aZkegx5mlv4FMYXv5w</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central</source><creator>Yang, Lun ; Wang, Kejian ; Chen, Jian ; Jegga, Anil G ; Luo, Heng ; Shi, Leming ; Wan, Chunling ; Guo, Xizhi ; Qin, Shengying ; He, Guang ; Feng, Guoyin ; He, Lin</creator><contributor>Altman, Russ B.</contributor><creatorcontrib>Yang, Lun ; Wang, Kejian ; Chen, Jian ; Jegga, Anil G ; Luo, Heng ; Shi, Leming ; Wan, Chunling ; Guo, Xizhi ; Qin, Shengying ; He, Guang ; Feng, Guoyin ; He, Lin ; Altman, Russ B.</creatorcontrib><description>In the era of personalized medical practice, understanding the genetic basis of patient-specific adverse drug reaction (ADR) is a major challenge. Clozapine provides effective treatments for schizophrenia but its usage is limited because of life-threatening agranulocytosis. A recent high impact study showed the necessity of moving clozapine to a first line drug, thus identifying the biomarkers for drug-induced agranulocytosis has become important. Here we report a methodology termed as antithesis chemical-protein interactome (CPI), which utilizes the docking method to mimic the differences in the drug-protein interactions across a panel of human proteins. Using this method, we identified HSPA1A, a known susceptibility gene for CIA, to be the off-target of clozapine. Furthermore, the mRNA expression of HSPA1A-related genes (off-target associated systems) was also found to be differentially expressed in clozapine treated leukemia cell line. Apart from identifying the CIA causal genes we identified several novel candidate genes which could be responsible for agranulocytosis. Proteins related to reactive oxygen clearance system, such as oxidoreductases and glutathione metabolite enzymes, were significantly enriched in the antithesis CPI. This methodology conducted a multi-dimensional analysis of drugs' perturbation to the biological system, investigating both the off-targets and the associated off-systems to explore the molecular basis of an adverse event or the new uses for old drugs.</description><identifier>ISSN: 1553-7358</identifier><identifier>ISSN: 1553-734X</identifier><identifier>EISSN: 1553-7358</identifier><identifier>DOI: 10.1371/journal.pcbi.1002016</identifier><identifier>PMID: 21483481</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adverse and side effects ; Agranulocytosis ; Agranulocytosis - chemically induced ; Benzodiazepines - pharmacology ; Biology ; Biomarkers ; Biomarkers - metabolism ; Case studies ; Cell Line, Tumor ; Chemistry ; Clozapine ; Clozapine - adverse effects ; Complications and side effects ; Computational Biology - methods ; Dimensional analysis ; Dosage and administration ; Drug therapy ; Drug-Related Side Effects and Adverse Reactions - chemically induced ; Drugs ; GABA Antagonists - adverse effects ; Gene expression ; Granulocytopenia ; HSP70 Heat-Shock Proteins - genetics ; Humans ; Medicine ; Protein Interaction Mapping - methods ; Proteins ; Proteomics - methods ; Reactive Oxygen Species ; Retrospective Studies ; Risk Factors ; Schizophrenia ; Studies</subject><ispartof>PLoS computational biology, 2011-03, Vol.7 (3), p.e1002016</ispartof><rights>COPYRIGHT 2011 Public Library of Science</rights><rights>Yang et al. 2011</rights><rights>2011 Yang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Yang L, Wang K, Chen J, Jegga AG, Luo H, et al. (2011) Exploring Off-Targets and Off-Systems for Adverse Drug Reactions via Chemical-Protein Interactome -- Clozapine-Induced Agranulocytosis as a Case Study. PLoS Comput Biol 7(3): e1002016. doi:10.1371/journal.pcbi.1002016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c632t-d743999f8614c1b08024b88ed6d56abe09ed9aae1993958ba65749a958a66a1b3</citedby><cites>FETCH-LOGICAL-c632t-d743999f8614c1b08024b88ed6d56abe09ed9aae1993958ba65749a958a66a1b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068927/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068927/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21483481$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Altman, Russ B.</contributor><creatorcontrib>Yang, Lun</creatorcontrib><creatorcontrib>Wang, Kejian</creatorcontrib><creatorcontrib>Chen, Jian</creatorcontrib><creatorcontrib>Jegga, Anil G</creatorcontrib><creatorcontrib>Luo, Heng</creatorcontrib><creatorcontrib>Shi, Leming</creatorcontrib><creatorcontrib>Wan, Chunling</creatorcontrib><creatorcontrib>Guo, Xizhi</creatorcontrib><creatorcontrib>Qin, Shengying</creatorcontrib><creatorcontrib>He, Guang</creatorcontrib><creatorcontrib>Feng, Guoyin</creatorcontrib><creatorcontrib>He, Lin</creatorcontrib><title>Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study</title><title>PLoS computational biology</title><addtitle>PLoS Comput Biol</addtitle><description>In the era of personalized medical practice, understanding the genetic basis of patient-specific adverse drug reaction (ADR) is a major challenge. Clozapine provides effective treatments for schizophrenia but its usage is limited because of life-threatening agranulocytosis. A recent high impact study showed the necessity of moving clozapine to a first line drug, thus identifying the biomarkers for drug-induced agranulocytosis has become important. Here we report a methodology termed as antithesis chemical-protein interactome (CPI), which utilizes the docking method to mimic the differences in the drug-protein interactions across a panel of human proteins. Using this method, we identified HSPA1A, a known susceptibility gene for CIA, to be the off-target of clozapine. Furthermore, the mRNA expression of HSPA1A-related genes (off-target associated systems) was also found to be differentially expressed in clozapine treated leukemia cell line. Apart from identifying the CIA causal genes we identified several novel candidate genes which could be responsible for agranulocytosis. Proteins related to reactive oxygen clearance system, such as oxidoreductases and glutathione metabolite enzymes, were significantly enriched in the antithesis CPI. This methodology conducted a multi-dimensional analysis of drugs' perturbation to the biological system, investigating both the off-targets and the associated off-systems to explore the molecular basis of an adverse event or the new uses for old drugs.</description><subject>Adverse and side effects</subject><subject>Agranulocytosis</subject><subject>Agranulocytosis - chemically induced</subject><subject>Benzodiazepines - pharmacology</subject><subject>Biology</subject><subject>Biomarkers</subject><subject>Biomarkers - metabolism</subject><subject>Case studies</subject><subject>Cell Line, Tumor</subject><subject>Chemistry</subject><subject>Clozapine</subject><subject>Clozapine - adverse effects</subject><subject>Complications and side effects</subject><subject>Computational Biology - methods</subject><subject>Dimensional analysis</subject><subject>Dosage and administration</subject><subject>Drug therapy</subject><subject>Drug-Related Side Effects and Adverse Reactions - chemically induced</subject><subject>Drugs</subject><subject>GABA Antagonists - adverse effects</subject><subject>Gene expression</subject><subject>Granulocytopenia</subject><subject>HSP70 Heat-Shock Proteins - genetics</subject><subject>Humans</subject><subject>Medicine</subject><subject>Protein Interaction Mapping - methods</subject><subject>Proteins</subject><subject>Proteomics - methods</subject><subject>Reactive Oxygen Species</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Schizophrenia</subject><subject>Studies</subject><issn>1553-7358</issn><issn>1553-734X</issn><issn>1553-7358</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqVkttq3DAQhk1paQ7tG5TW0KteeKuDLVk3hRDSdCG00MO1GEuyo8WWFklesn2OPnC12U3IQm-KBBqNvvkHzUxRvMFogSnHH1d-Dg7GxVp1doERIgizZ8Upbhpacdq0z5_YJ8VZjCuEsinYy-KE4LqldYtPiz9Xd-vRB-uG0vd9lSAMJsUSnL6_x21MZopl70MJemNCNKUO81AGAypZ72K5sVCqWzNZBWO1Dj4Z60rrkgmZ8JOpKjX637C2zlTW6VkZXcIQwM2jV9vko83p8i4VZPGYZr19VbzoYYzm9eE8L359vvp5-aW6-Xa9vLy4qRSjJFWa11QI0bcM1wp3qEWk7trWaKYbBp1BwmgBYLAQVDRtB6zhtYBsAmOAO3pevNvr5hJEeSholJjm1daCoEws94T2sJLrYCcIW-nBynuHD4OEkKwajaSE5xagjmPS1x3nwGtCG96D4A1Cvcpanw7Z5m4yWhmXAoxHoscvzt7KwW8kRawVhGeB93uBAXI-63qfMTXZqOQFaSgjXDQkU4t_UHnpXY-8M73N_qOAD0cBmUnmLg0wxyiXP77_B_v1mK33rAo-xmD6x69iJHcj_FBxuRtheRjhHPb2aZkegx5mlv4FMYXv5w</recordid><startdate>20110301</startdate><enddate>20110301</enddate><creator>Yang, Lun</creator><creator>Wang, Kejian</creator><creator>Chen, Jian</creator><creator>Jegga, Anil G</creator><creator>Luo, Heng</creator><creator>Shi, Leming</creator><creator>Wan, Chunling</creator><creator>Guo, Xizhi</creator><creator>Qin, Shengying</creator><creator>He, Guang</creator><creator>Feng, Guoyin</creator><creator>He, Lin</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISN</scope><scope>ISR</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20110301</creationdate><title>Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study</title><author>Yang, Lun ; Wang, Kejian ; Chen, Jian ; Jegga, Anil G ; Luo, Heng ; Shi, Leming ; Wan, Chunling ; Guo, Xizhi ; Qin, Shengying ; He, Guang ; Feng, Guoyin ; He, Lin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c632t-d743999f8614c1b08024b88ed6d56abe09ed9aae1993958ba65749a958a66a1b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adverse and side effects</topic><topic>Agranulocytosis</topic><topic>Agranulocytosis - chemically induced</topic><topic>Benzodiazepines - pharmacology</topic><topic>Biology</topic><topic>Biomarkers</topic><topic>Biomarkers - metabolism</topic><topic>Case studies</topic><topic>Cell Line, Tumor</topic><topic>Chemistry</topic><topic>Clozapine</topic><topic>Clozapine - adverse effects</topic><topic>Complications and side effects</topic><topic>Computational Biology - methods</topic><topic>Dimensional analysis</topic><topic>Dosage and administration</topic><topic>Drug therapy</topic><topic>Drug-Related Side Effects and Adverse Reactions - chemically induced</topic><topic>Drugs</topic><topic>GABA Antagonists - adverse effects</topic><topic>Gene expression</topic><topic>Granulocytopenia</topic><topic>HSP70 Heat-Shock Proteins - genetics</topic><topic>Humans</topic><topic>Medicine</topic><topic>Protein Interaction Mapping - methods</topic><topic>Proteins</topic><topic>Proteomics - methods</topic><topic>Reactive Oxygen Species</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Schizophrenia</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Lun</creatorcontrib><creatorcontrib>Wang, Kejian</creatorcontrib><creatorcontrib>Chen, Jian</creatorcontrib><creatorcontrib>Jegga, Anil G</creatorcontrib><creatorcontrib>Luo, Heng</creatorcontrib><creatorcontrib>Shi, Leming</creatorcontrib><creatorcontrib>Wan, Chunling</creatorcontrib><creatorcontrib>Guo, Xizhi</creatorcontrib><creatorcontrib>Qin, Shengying</creatorcontrib><creatorcontrib>He, Guang</creatorcontrib><creatorcontrib>Feng, Guoyin</creatorcontrib><creatorcontrib>He, Lin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Canada</collection><collection>Science in Context</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PLoS computational biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Lun</au><au>Wang, Kejian</au><au>Chen, Jian</au><au>Jegga, Anil G</au><au>Luo, Heng</au><au>Shi, Leming</au><au>Wan, Chunling</au><au>Guo, Xizhi</au><au>Qin, Shengying</au><au>He, Guang</au><au>Feng, Guoyin</au><au>He, Lin</au><au>Altman, Russ B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study</atitle><jtitle>PLoS computational biology</jtitle><addtitle>PLoS Comput Biol</addtitle><date>2011-03-01</date><risdate>2011</risdate><volume>7</volume><issue>3</issue><spage>e1002016</spage><pages>e1002016-</pages><issn>1553-7358</issn><issn>1553-734X</issn><eissn>1553-7358</eissn><abstract>In the era of personalized medical practice, understanding the genetic basis of patient-specific adverse drug reaction (ADR) is a major challenge. Clozapine provides effective treatments for schizophrenia but its usage is limited because of life-threatening agranulocytosis. A recent high impact study showed the necessity of moving clozapine to a first line drug, thus identifying the biomarkers for drug-induced agranulocytosis has become important. Here we report a methodology termed as antithesis chemical-protein interactome (CPI), which utilizes the docking method to mimic the differences in the drug-protein interactions across a panel of human proteins. Using this method, we identified HSPA1A, a known susceptibility gene for CIA, to be the off-target of clozapine. Furthermore, the mRNA expression of HSPA1A-related genes (off-target associated systems) was also found to be differentially expressed in clozapine treated leukemia cell line. Apart from identifying the CIA causal genes we identified several novel candidate genes which could be responsible for agranulocytosis. Proteins related to reactive oxygen clearance system, such as oxidoreductases and glutathione metabolite enzymes, were significantly enriched in the antithesis CPI. This methodology conducted a multi-dimensional analysis of drugs' perturbation to the biological system, investigating both the off-targets and the associated off-systems to explore the molecular basis of an adverse event or the new uses for old drugs.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>21483481</pmid><doi>10.1371/journal.pcbi.1002016</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1553-7358
ispartof PLoS computational biology, 2011-03, Vol.7 (3), p.e1002016
issn 1553-7358
1553-734X
1553-7358
language eng
recordid cdi_plos_journals_1313184920
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central
subjects Adverse and side effects
Agranulocytosis
Agranulocytosis - chemically induced
Benzodiazepines - pharmacology
Biology
Biomarkers
Biomarkers - metabolism
Case studies
Cell Line, Tumor
Chemistry
Clozapine
Clozapine - adverse effects
Complications and side effects
Computational Biology - methods
Dimensional analysis
Dosage and administration
Drug therapy
Drug-Related Side Effects and Adverse Reactions - chemically induced
Drugs
GABA Antagonists - adverse effects
Gene expression
Granulocytopenia
HSP70 Heat-Shock Proteins - genetics
Humans
Medicine
Protein Interaction Mapping - methods
Proteins
Proteomics - methods
Reactive Oxygen Species
Retrospective Studies
Risk Factors
Schizophrenia
Studies
title Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A51%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exploring%20off-targets%20and%20off-systems%20for%20adverse%20drug%20reactions%20via%20chemical-protein%20interactome--clozapine-induced%20agranulocytosis%20as%20a%20case%20study&rft.jtitle=PLoS%20computational%20biology&rft.au=Yang,%20Lun&rft.date=2011-03-01&rft.volume=7&rft.issue=3&rft.spage=e1002016&rft.pages=e1002016-&rft.issn=1553-7358&rft.eissn=1553-7358&rft_id=info:doi/10.1371/journal.pcbi.1002016&rft_dat=%3Cgale_plos_%3EA253627952%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c632t-d743999f8614c1b08024b88ed6d56abe09ed9aae1993958ba65749a958a66a1b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/21483481&rft_galeid=A253627952&rfr_iscdi=true